83944 Federal Register / Vol. 88, No. 230 / Friday, December 1, 2023 / Notices 

Senior Executive Service and Senior 

Level members; and (2) making 

recommendations on other performance 

management issues, such as pay 

adjustments, bonuses, and Presidential 

Rank Awards. The names, position 

titles, and appointment types of each 

member of the PRB are set forth below: 

1. Sylvia Rosabal, Director, Office of 

Cuba Broadcasting, Non-Career SES 

2. Grant Turner, Chief Financial Officer, 

Career SES 

3. David Kotz, Chief Management 

Officer, Career SES 

Dated: November 27, 2023. 

Armanda Matthews, 

Program Support Specialist, U.S. Agency for 

Global Media. 

[FR Doc. 2023–26476 Filed 11–30–23; 8:45 am] 

BILLING CODE 8610–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Readiness and Response; (Formerly 

Known as the Board of Scientific 

Counselors, Center for Preparedness 

and Response); Notice of Charter 

Renewal 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of charter renewal. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), announces the renewal 

of the charter of the Board of Scientific 

Counselors, Office of Readiness and 

Response (BSC, ORR); (formerly known 

as the Board of Scientific Counselors, 

Center for Preparedness and Response 

(BSC, CPR)). 

FOR FURTHER INFORMATION CONTACT: Ian 

Williams, Ph.D., M.S., Designated 

Federal Officer, Board of Scientific 

Counselors, Office of Readiness and 

Response, Centers for Disease Control 

and Prevention, Department of Health 

and Human Services, 1600 Clifton Road 

NE, Mailstop H21–5, Atlanta, Georgia 

30329–4027. Telephone: (404) 639– 

2210; Email: IWilliams@cdc.gov. 

SUPPLEMENTARY INFORMATION: CDC is 

providing notice under 5 U.S.C. 1001– 

1014 of the renewal of the charter of the 

Board of Scientific Counselors, Office of 

Readiness and Response (formerly 

known as the Board of Scientific 

Counselors, Center for Preparedness and 

Response), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. This charter has 

been renewed for a two-year period 

through November 5, 2025. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–26420 Filed 11–30–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0116] 

CDC Recommendations for Hepatitis C 

Testing Among Perinatally Exposed 

Infants and Children—United States, 

2023 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: General notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), announces the 

availability of the final CDC 

Recommendations for Hepatitis C 

Testing Among Perinatally Exposed 

Infants and Children—United States, 

2023. 

DATES: The final document was 

published as an MMWR Reports & 

Recommendations on November 3, 

2023. 

ADDRESSES: The document may be 

found in the docket at 

www.regulations.gov, Docket No. CDC– 

2022–0116 and at https://www.cdc.gov/ 

mmwr/volumes/72/rr/rr7204a1.htm?s_

cid=rr7204a1_w. 

FOR FURTHER INFORMATION CONTACT: 

Lakshmi Panagiotakopoulos, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop U12–3, 

Atlanta, GA 30329. Telephone: 404– 

639–8000; Email: DVHpolicy@cdc.gov. 

SUPPLEMENTARY INFORMATION: In 2021, 

CDC determined that Recommendations 

for Hepatitis C Testing Among 

Perinatally Exposed Infants and 

Children—United States, 2023 

constituted influential scientific 

information (ISI) that will have a clear 

and substantial impact on important 

public policies and private sector 

decisions. As such, the 

recommendations underwent peer 

review as required by Part II Section D 

of the HHS Information Quality 

Guidelines (https://aspe.hhs.gov/hhsguidelines-ensuring-maximizingdisseminated-information). HHS 

developed these guidelines in 

accordance with the OMB issued 

Guidelines for Ensuring and 

Maximizing the Quality, Objectivity, 

Utility, and Integrity of lnformation 

Disseminated by Federal Agencies, 67 

FR 8452 (Feb. 22, 2002) and the 

Information Quality Act Public Law 

106–554, 515(a) (2000). CDC elected to 

use specialists in the field who were not 

involved in the development of the 

recommendations. CDC solicited 

nominations for reviewers from the 

American Academy of Family 

Physicians, American Academy of 

Pediatrics, American Association for the 

Study of Liver Diseases, American 

College of Obstetricians and 

Gynecologists, and the North American 

Society for Pediatric Gastroenterology, 

Hepatology & Nutrition. Six clinicians 

with expertise in hepatology, 

gastroenterology, internal medicine, 

infectious diseases, and/or pediatrics 

provided structured peer reviews. 

Specifically, CDC asked reviewers to 

focus their reviews on the following 

criteria: 

• Methodology (studies included in the 

evidence review, methods used to 

assess the evidence, clarity of 

evidence findings, identification of 

limitations or uncertainties) 

• Recommendations (reviewer 

agreement with CDC’s conclusions, 

suggestions for clarifying 

recommendations) 

• Potential impact and implementation 

(whether implementing 

recommendations would improve 

health outcomes, any resources or 

tools that would facilitate 

implementation) 

• Other comments for CDC 

consideration 

A list of peer reviewers and CDC’s 

responses to peer review comments are 

available at CDC’s Viral Hepatitis 

Influential Scientific Information web 

page at https://www.cdc.gov/hepatitis/ 

policy/isireview/index.htm. 

In addition, on November 22, 2022, 

CDC published a notice in the Federal 

Register (87 FR 71330) to obtain public 


lotter on DSK11XQN23PROD with NOTICES1